Racial and Ethnic Representation of Participants in US Clinical Trials of New Drugs and Biologics-Reply

JAMA. 2022 Mar 8;327(10):985. doi: 10.1001/jama.2022.0878.

Authors

Milena Lolic¹, Richardae Araojo¹, Janet Woodcock¹

Affiliation

¹ Office of the Commissioner, US Food and Drug Administration, Silver Spring, Maryland.

PMID: 35258535
DOI: 10.1001/jama.2022.0878

No abstract available

Publication types

Letter
Comment

MeSH terms

Biological Products* / therapeutic use
Ethnicity
Humans
Racial Groups

Substances

Biological Products